BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer

Onkologie

Volumn 30, Issue 6, 2007, Pages 316-318

  Breuer, A ^a,e   Kandel, M ^a,b   Fisseler Eckhoff, A ^a   Sutter, C ^c   Schwaab, E ^d   Luck H ^a   Bois, A ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Fachärztin für Humangenetik   (Germany)

^e Klinik für Gynäkologie and Gynäkologische Onkologie   (Germany)

Author keywords

BRCA1 mutation; Breast cancer, basal like; Squamous cell cancer of the breast

Indexed keywords

BRCA1 PROTEIN; CAPECITABINE; CARBOPLATIN; DOCETAXEL; EPIRUBICIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CYTOPATHOLOGY; DISEASE FREE SURVIVAL; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GERM LINE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; PARTIAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL METAPLASIA; TISSUE SECTION;

ADULT; BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; GERM-LINE MUTATION; HUMANS; MUTATION, MISSENSE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY;

EID: 34249938087     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101515     Document Type: Article

References (29)

1. Tavassoéli FA, Devilee P: IARC WHO Classification of Tumours, No. 4; Pathology and Genetics: Tumours of the Breast and Female Genital Organs. Lyon, WHO Press, 2003.
2. Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN: Squamous cell carcinoma of the breast. J Clin Oncol 2005;23:7827-7835.
3. Menes T, Schachter J, Morgenstern S, Fenig E, Lurie H, Gutman H: Primary squamous cell carcinoma (SqCC) of the breast. Am J Clin Oncol 2003; 26:571-573.
4. Behranwala KA, Nasiri N, Abdullah N, Trott PA, Gui GP: Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome. Eur J Surg Oncol 2003;29:386-389.
5. Siegelmann-Danieli N, Murphy TJ, Meschter SC, Stein ME, Prichard J: Primary pure squamous cell carcinoma of the breast. Clin Breast Cancer 2005;6: 270-272.
6. Tayeb K, Saadi I, Kharmash M, Hadadi K, El Omari-Alaoui H, El Ghazi E, Mansouri A, Errihani H, Benjaafar N, El Gueddari BK: Primary squamous cell carcinoma of the breast: report of three cases. Cancer Radiother 2002;6:366-368.
7. Grunwald R, Ohlinger R, Schwesinger G, Köhler G: Primäres intrazystisches Plattenepithelkarzinom der Brust. Zentralbl Gynakol 2004;126:36-40.
8. Weigel RJ, Ikeda DM, Nowels KW: Primary squamous cell carcinoma of the breast. South Med J 1996;89:511-515.
9. Moisidis E, Ahmed S, Carmalt H, Gillett D: Primary squamous cell carcinoma of the breast. Aust N Z J Surg 2002;72:65-67.
10. Cardoso F, Leal C, Meira A, Azevedo R, Mauricio MJ, Leal da Silva JM, Lopes C, Pinto Ferreira E: Squamous cell carcinoma of the breast. Breast 2000;9:315-319.
11. Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski R: Primary squamous carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. J Surg Oncol 1995;59:199-203.
12. Turner N, Tutt A, Ashorth A: Hallmarks of 'BRCA-ness' in sporadic cancers. Nat Rev Cancer 2004;4:814-819.
13. Narod SA, Offit K: Prevention and management of hereditary breast cancer. J Clin Oncol 2005;23: 1656-1663.
14. Offit K: Are BRCA1- and BRCA2-associated breast cancers different? J Clin Oncol 2000;18: 104-106.
15. Sorlie T: Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 2004;40:2667-2675.
16. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-5374.
17. Brenton JD, Carey LA, Ahmed AA, Caldas C: Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005;23:7350-7360.
18. German Consortium for Hereditary Breast and Ovarian Cancer: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002;97:472-480.
19. Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, Lakhani SR, Smith IE: Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 2006;59:729-735.
20. Laakso M, Loman N, Borg A, Isola J: Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol 2005;18: 1321-1328.
21. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D, Brown P: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002;161:1991-1996.
22. Laakso M, Tanner M, Nilsson J, Wiklund T, Erikstein B, Kellokumpu-Lehtinen P, Malmström P, Wilking N, Bergh J, Isola J: Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. Clin Cancer Res 2006;12:1485-1491.
23. Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adélaide J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, Charpin C, Jacquemier J, Birnbaum D: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res 2006;66: 4636-4644.
24. Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen L: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003;95:1482-1485.
25. Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ: Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 1999;59:2011-2017.
26. Kennedy RD, Quinn JE, Johnston PG, Harkin DP: The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 2004;96: 1659-1668.
27. Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Boland CR, Venuta S: BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer 2003;88:1285-1291.
28. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Kramling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF; Breast Cancer Linkage Consortium: Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005;11:5175-5180.
29. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005;434:917-921.